Alpha CognitionACOG 32 9-Day RSI is 57.72 as of Jun. 27, 2026. GuruFocus rates ACOG with a GF Score™ of 32/100. The stock has 3 warning signs investors should review. Among 1,425 Biotechnology companies, Alpha Cognition ranks worse than 76.14% on this metric.
The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100. Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A shorter period RSI is more reactive to recent price changes, so it can show early signs of reversals. 9-Day RSI is sometimes used together with 14-Day RSI in a two period divergence strategy.
As of today (2026-06-27), Alpha Cognition's 9-Day RSI is 57.72.
The industry rank for Alpha Cognition's 9-Day RSI or its related term are showing as below:
ACOG's 9-Day RSI is ranked worse than 76.14% of 1425
companies
in the Biotechnology industry
Industry Median: 45
vs ACOG: 57.72
Alpha Cognition (NAS:ACOG) 9-Day RSI Explanation
The Relative Strength Index (RSI), developed by J. Welles Wilder in his book “New Concepts in Technical Trading Systems.”, is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100.
Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A RSI surpasses the 30 level indicates a bullish sign, when it slides below 70 level, it’s a bearish sign. This level can be adjusted depending on the security’s pattern and the market’s underlying trend. In an uptrend or bullish market, the RSI might range within a higher interval, investors could set the support level higher. If a downtrend or bearish market occurs, investors may need to lower the resistance level.
RSI can also be used in trading techniques to indicate the trading signal, such as Divergences and Swing Rejections. A shorter period RSI is more reactive to recent price changes, so it can show early signs of reversals. 9-Day RSI is sometimes used together with 14-Day RSI in a two period divergence strategy.
Alpha Cognition 9-Day RSI Related Terms
ACOG vs GNLX, VTVT, CRDF: 9-Day RSI Comparison
For the Biotechnology subindustry, Alpha Cognition's 9-Day RSI, along with its competitors' market caps and 9-Day RSI data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Alpha Cognition 9-Day RSI vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Alpha Cognition's 9-Day RSI distribution charts can be found below:
* The bar in red indicates where Alpha Cognition's 9-Day RSI falls into.
* Note that the formula uses a positive value for the average loss.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Alpha Cognition (ACOG) has a 9-Day RSI of 57.72 as of Jun. 27, 2026. According to the industry distribution chart, Alpha Cognition ranks #1085 out of 1425 companies in the Biotechnology industry, placing it in the top 76.1%.
Is Alpha Cognition's 9-Day RSI too high?
Alpha Cognition's current 9-Day RSI is 57.72. The Biotechnology industry median 9-Day RSI is 45.00. Alpha Cognition's value of 57.72 is 28.3% above this industry median. Based on the distribution chart, Alpha Cognition ranks #1085 out of 1425 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Alpha Cognition has a GF Score™ of 32/100, reflecting its overall financial health beyond just this single metric.
How does Alpha Cognition's 9-Day RSI compare to GNLX and VTVT?
According to the Biotechnology industry distribution chart, Alpha Cognition ranks #1085 out of 1425 companies for 9-Day RSI. This places Alpha Cognition in the lower half of its industry. The industry median 9-Day RSI is 45.00. Alpha Cognition's value of 57.72 is 28.3% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 9-Day RSI for a Biotechnology company?
The median 9-Day RSI among Biotechnology companies is 45.00, based on 1,425 companies in the industry. Companies in the top quartile (top 25%) have a 9-Day RSI significantly above this median, while those in the bottom quartile fall well below. However, 9-Day RSI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Alpha Cognition's current 9-Day RSI of 57.72 is 28.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 9-Day RSI mean?
A high 9-Day RSI can signal that a stock is expensive relative to its fundamentals. For the Biotechnology industry, the median 9-Day RSI is 45.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Alpha Cognition's current 9-Day RSI is 57.72. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Alpha Cognition stock overvalued right now?
Alpha Cognition (ACOG) has a current 9-Day RSI of 57.72. The current 9-Day RSI is 57.72 and 28.3% above the Biotechnology industry median of 45.00. Alpha Cognition's overall GF Score™ is 32/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 9-Day RSI calculated?
9-Day RSI is calculated from a company's financial statements. For Alpha Cognition (ACOG), the current 9-Day RSI is 57.72 as of Jun. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Alpha Cognition Inc is a biopharmaceutical company dedicated to developing treatments for patients suffering from neurodegenerative diseases, such as Alzheimers disease, for which there are limited or no treatment options. The Companies current focus is on the commercial manufacturing and sales of ZUNVEYL oral tablet formulation. The Companies commercial development program for ZUNVEYL is focused on building a long-term care commercial team that can focus on providing key points of differentiation, exploiting key issues with existing Acetylcholinesterase inhibitors treatments, and seeking potential licensing partners for other additional indications and new formulations.
32GF Score
Get the complete analysis for ACOG
9-Day RSI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ACOG has been successfully added to your 